TY - JOUR
T1 - Dual-Channel Fluorescent Probe for the Detection of Peroxynitrite and Glutathione in Mitochondria
T2 - Accurate Discrimination of Inflammatory and Progressing Tumor Cells
AU - Luo, Xianzhu
AU - Zhang, Cuiling
AU - Yuan, Fang
AU - Cheng, Shasha
AU - Zhu, Yingxin
AU - Xiang, Miaomiao
AU - Hu, Xinyu
AU - Xian, Yuezhong
N1 - Publisher Copyright:
© 2022 American Chemical Society. All rights reserved.
PY - 2022/11/15
Y1 - 2022/11/15
N2 - Distinguishing between normal, inflammatory, and progressing tumor cells plays a vital role in early diagnoses and clinical studies. The simultaneous quantification of multiple biomarkers in cells can reveal cellular heterogeneity, which contributes to the discrimination of different types of cells. Herein, a dual-channel fluorescent probe has been developed for monitoring peroxynitrite (ONOO-) and glutathione (GSH) to accurately discriminate normal cells, inflammatory cells, and progressing cancer cells. The probe can monitor exogenous and endogenous mitochondrial GSH and ONOO-in living cells and zebrafish by green (530 nm, G530) and red (630 nm, R630) emission based on its good selectivity and low biotoxicity. GSH and ONOO-are visualized via fluorescence imaging, and the corresponding output signals can be employed to differentiate nontumorigenic, malignant, and metastatic breast cells in cocultured cells. Furthermore, the accurate discrimination among normal, inflammatory, and cancerous cells is achieved through the changes in the dual-channel fluorescence signal, which shows great potential for the diagnosis of inflammation and cancer diseases.
AB - Distinguishing between normal, inflammatory, and progressing tumor cells plays a vital role in early diagnoses and clinical studies. The simultaneous quantification of multiple biomarkers in cells can reveal cellular heterogeneity, which contributes to the discrimination of different types of cells. Herein, a dual-channel fluorescent probe has been developed for monitoring peroxynitrite (ONOO-) and glutathione (GSH) to accurately discriminate normal cells, inflammatory cells, and progressing cancer cells. The probe can monitor exogenous and endogenous mitochondrial GSH and ONOO-in living cells and zebrafish by green (530 nm, G530) and red (630 nm, R630) emission based on its good selectivity and low biotoxicity. GSH and ONOO-are visualized via fluorescence imaging, and the corresponding output signals can be employed to differentiate nontumorigenic, malignant, and metastatic breast cells in cocultured cells. Furthermore, the accurate discrimination among normal, inflammatory, and cancerous cells is achieved through the changes in the dual-channel fluorescence signal, which shows great potential for the diagnosis of inflammation and cancer diseases.
UR - https://www.scopus.com/pages/publications/85141734617
U2 - 10.1021/acs.analchem.2c03577
DO - 10.1021/acs.analchem.2c03577
M3 - 文章
AN - SCOPUS:85141734617
SN - 0003-2700
VL - 94
SP - 15790
EP - 15800
JO - Analytical Chemistry
JF - Analytical Chemistry
IS - 45
ER -